The COVID-19 Pandemic – Products

Product News
NIH and Exothera Collaborate To Produce GMP Intranasal Vaccine Against SARS-CoV-2
The National Institutes of Health selected Exothera S.A. therapeutics to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.

Whitepaper
The Future of Diagnostics
While the industry was put front and center during the COVID-19 pandemic, diagnostics have always been critical in treating illnesses and managing health. Technological advances, innovative platforms, and decentralized test options are driving exciting developments and optimism across the diagnostics industry.

Product News
Nanopore Technology Achieves Breakthrough in Protein Variant Detection
A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.

Product News
Integrated DNA Technologies Launches New Respiratory Virus Panel
New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow.

Product News
PrecisionLife Identifies First Detailed Genetic Risk Factors for Long COVID and Other Complex Diseases
PrecisionLife, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome.

Product News
INTEGRA Pipetting Solutions Accelerate Crucial Viral Genomics Research
The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.

Product News
Meissa Vaccines Enters into CGMP Manufacturing Agreement for Pediatric RSV Vaccine Candidate for Phase 2 Clinical Trials
Meissa Vaccines announced it has entered into a manufacturing agreement with Exothera S.A. delivering customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids.

Product News
Honeycomb Biotechnologies and Revvity Launch New Solutions To Expand the Frontiers of Single Cell Research
Honeycomb Biotechnologies and Revvity have announced the launch of a suite of new solutions and services that expand the frontiers of single-cell biology.

Whitepaper
Overcoming the Challenges that Delay Development of Your Lateral Flow Assay
Novice and expert in vitro diagnostics (IVD) manufacturers agree that developing, optimizing, and launching a lateral flow assay (LFA) test is never routine nor easy.

Product News
World First: Multiomics Biosignal Detection in Real-Time via an Electronic Biosensor
Paragraf San Diego - presented novel multiomics capabilities, by detection of both protein and RNA biosignals simultaneously on a single graphene-based biosensor.
Advertisement